European Primary Care Cardiovascular Society

Variability of lipid levels is predictive of CV events

Apr. 12, 2018 - Waters DD, et al. - J Clin Lipidol 2018

Visit-to-visit variability in fasting measurements of HDL-c, TG, and LDL-c is predictive of coronary events, CV events, and TG and LDL-c variability is also predictive of incident diabetes.

Slides | Type 2 diabetes & cardiovascular disease update

Mar. 15, 2018 - Barcelona, Spain - Dr. Xavier Cos - Barcelona, Spain
**EPCCS 2018** Slides prepared and presented by Dr. Xavier Cos (Barcelona, Spain), here offered as an educational service.

Diabetes and vascular disease: epidemiology and management options

Dr. Xavier Cos - Barcelona, Spain

EPCCS 2018 An impression of the presentation of dr. Xavier Cos on diabetes and vascular disease, epidemiology and management options, given during the Annual EPCCS CV Summit.

Complication risk in diabetes can be predicted with new stratification

Mar. 7, 2018 - Ahlqvist E et al. - Lancet Diab Endocrinol 2018

In a data-driven cluster analysis of 6 variables in adult patients with newly diagnosed diabetes, 5 categories of patients were identified with different characteristics and risks of complications.

Children with a higher BMI have an increased risk of cardio-metabolic disease later in life

Mar. 1, 2018 - Geng T, et al. - Diabetes Care 2018

A genetic predisposition to higher childhood BMI was associated with an increased risk of type 2 diabetes, coronary artery disease, and cardio-metabolic traits in adult life.

Stimulating health behaviour changes to reduce cardiovascular risk in primary care

Scroll down to download a free copy

EPCCS Consensus Guidance for Primary Care
EPCCS Consensus Guidance for Primary Care

Lifestyle importantly contributes to preventable morbidity and mortality. This EPCCS guidance document outlines the presented evidence on ingredients of successful behaviour change strategies and motivational interviewing, as well as which CV risk behaviours and clinical outcomes may be improved with various types of strategies.

Increased mortality and morbidity risk in older ischemic stroke patients with diabetes

Feb. 21, 2018 - Echouffo-Tcheugui JB, et al. - Eur Heart J 2018

In patients with ischemic stroke ≥ 65 years, diabetes is associated with a higher risk of mortality, recurrent events, HF and hospitalisations.

Novel GLP-1 analogue in once-weekly formula receives EU approval as T2DM therapy

Feb. 12, 2018 - news

The European Commission has granted marketing authorization for semaglutide as monotherapy or in combination with other agents, for the treatment of adults with type 2 diabetes.

Gestational DM increases risk of T2DM, hypertension and IHD

Jan. 29, 2018 - Daly B et al., - PLoS Medicine, 2018

Population-based study shows that women with GDM are over 20 times more likely to develop T2DM and have an almost doubled risk of hypertension, and 2.8-fold higher risk of IHD, compared with control.

Striking results for weight reduction in T2DM in primary care based program

IDF 2017 - Abu Dhabi, UAE

Dec. 18, 2017 - IDF 2017 - Abu Dhabi, UAE - Prof Naveed Sattar, MD - Glasgow, UK
**IDF 2017** Prof Sattar reports on the results of the DIRECT trial evaluating the intervention with a weight management program with huge implications for clinical practice. Almost 75% of the patients in the intervention group had a weight loss >10 kg and half of the patients in this group had remission of diabetes after 1 year of the start of the trial.

IDF 2017 Prof Sattar reports on the results of the DiRECT trial evaluating a weight management program with huge implications for clinical practice. Almost half of the patients in the intervention group had remission of T2DM 1 year after the start of the trial.

Primary care-based dietary and lifestyle intervention leads to remission of T2DM

Dec. 11, 2017 - Lean MEJ et al., The Lancet 2017

The randomised DIRECT trial evaluated a practical weight management program. On average, weigh reduced by 10 kg and almost half achieved and maintained remission of T2DM at 12 months after starting the intervention.

Cognitive dysfunction in diabetic patients partly explained by hyperglycemia

Nov. 1, 2017 - Geijselaers SLC et al., Diabetes Care 2017

Differences in cognitive performance between diabetic patients and individuals with normal glucose levels can be explained by hyperglycemia and by BP-related variables, but not by insulin resistance.